Myriad Genetics | MYGN - Ebitda





Ebitda Veränderung Datum
Agilent USD 456M 84M 2025-12
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Danaher USD 1.84B 81M 2026-06
Illumina USD 330M 80M 2026-06
J&J USD 8.27B 1.08B 2026-03
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 648M 91M 2026-06
Quidel USD 129.3M 20.6M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Veracyte USD 43.96M 1.16M 2026-06
Waters USD 712M 545M 2026-06